Helen C. Adams insider trades
Open-market stock purchases and sales by Helen C. Adams, Director at Immix Biopharma, Inc, from SEC Form 4 filings since May 4, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +168%.
Open-market stock purchases and sales by Helen C. Adams, Director at Immix Biopharma, Inc, from SEC Form 4 filings since May 4, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +168%.